Kilitch Drugs Current Valuation vs. EBITDA
| KILITCH Stock | 315.60 4.95 1.59% |
For Kilitch Drugs profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Kilitch Drugs to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Kilitch Drugs Limited utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Kilitch Drugs's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Kilitch Drugs Limited over time as well as its relative position and ranking within its peers.
Kilitch |
Kilitch Drugs Limited EBITDA vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Kilitch Drugs's current stock value. Our valuation model uses many indicators to compare Kilitch Drugs value to that of its competitors to determine the firm's financial worth. Kilitch Drugs Limited is considered the number one company in current valuation category among its peers. It also is currently regarded as number one stock in ebitda category among its peers totaling about 0.06 of EBITDA per Current Valuation. The ratio of Current Valuation to EBITDA for Kilitch Drugs Limited is roughly 16.60 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Kilitch Drugs by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Kilitch Drugs' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.Kilitch Current Valuation vs. Competition
Kilitch Drugs Limited is considered the number one company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is now estimated at about 353.8 Billion. Kilitch Drugs claims roughly 4.75 Billion in current valuation contributing just under 2% to equities under Health Care industry.
Kilitch EBITDA vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Kilitch Drugs |
| = | 4.75 B |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a measure of a company operating cash flow based on data from the company income statement and is a very good way to compare companies within industries or across different sectors. However, unlike Operating Cash Flow, EBITDA does not include the effects of changes in working capital.
Kilitch Drugs |
| = | 286.33 M |
In a nutshell, EBITDA is calculated by adding back each of the excluded items to the post-tax profit, and can be used to compare companies with very different capital structures.
Kilitch EBITDA Comparison
Kilitch Drugs is currently under evaluation in ebitda category among its peers.
Kilitch Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Kilitch Drugs. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Kilitch Drugs position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Kilitch Drugs' important profitability drivers and their relationship over time.
Use Kilitch Drugs in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kilitch Drugs position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kilitch Drugs will appreciate offsetting losses from the drop in the long position's value.Kilitch Drugs Pair Trading
Kilitch Drugs Limited Pair Trading Analysis
The ability to find closely correlated positions to Kilitch Drugs could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kilitch Drugs when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kilitch Drugs - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kilitch Drugs Limited to buy it.
The correlation of Kilitch Drugs is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kilitch Drugs moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kilitch Drugs Limited moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kilitch Drugs can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Kilitch Drugs position
In addition to having Kilitch Drugs in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Music and Video Thematic Idea Now
Music and Video
Companies specializing in music, video and movie production and distribution. The Music and Video theme has 35 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Music and Video Theme or any other thematic opportunities.
| View All Next | Launch |
Other Information on Investing in Kilitch Stock
To fully project Kilitch Drugs' future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Kilitch Drugs Limited at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Kilitch Drugs' income statement, its balance sheet, and the statement of cash flows.